8月12日 - ** 药品分销商Cencora（COR.N）股价下跌5.3%，报316.19美元
** Cencora表示，自7月1日起，该公司此前负责处理的沃尔格林（Walgreens）部分处方药业务将不再由其负责
** 经纪公司Leerink Partners表示，沃尔格林虽占COR收入的很大一部分，但利润率极低
** “我们认为，该业务整体约占COR企业每股利润的3.0%至3.5%，”Leerink补充道
** 计入当日跌幅后，该股今年以来累计下跌5.5%
8月12日 - ** 药品分销商Cencora（COR.N）股价下跌5.3%，报316.19美元
** Cencora表示，自7月1日起，该公司此前负责处理的沃尔格林（Walgreens）部分处方药业务将不再由其负责
** 经纪公司Leerink Partners表示，沃尔格林虽占COR收入的很大一部分，但利润率极低
** “我们认为，该业务整体约占COR企业每股利润的3.0%至3.5%，”Leerink补充道
** 计入当日跌幅后，该股今年以来累计下跌5.5%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.